iShares Genomics Immunology and Healthcare ETF (IDNA)

NYSEArca • Currently up 0.02 (+0.05%) in today's trading session

1 member of Congress has disclosed 7 trades in iShares Genomics Immunology and Healthcare ETF (IDNA) via STOCK Act filings. The most recent disclosure was a sale by Sheldon Whitehouse on 3 March 2023. Aggregate disclosed activity totals roughly $24K in sales (midpoint estimates from bracketed disclosure amounts).

iShares Genomics Immunology and Healthcare ETF is currently trading at $41.79, positioned at 99% of its 52-week range ($22.76 – $42.02).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$41.79
24h Change
+0.02 (+0.05%)
52 Week Range
$22.76–$42.02
View on NASDAQ

iShares Genomics Immunology and Healthcare ETF Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IDNA

Select to highlight on chart
5 transactions
Compliance: 0%
Sheldon Whitehouse3 Mar 202313 Aug 2024SaleStock$1,001 - $15,000N/A
Sheldon Whitehouse3 Mar 202313 Aug 2024SaleStock$1,001 - $15,000N/A
Sheldon Whitehouse3 Mar 202313 Aug 2024SaleStock$1,001 - $15,000N/A
Sheldon Whitehouse2 Aug 202227 Sept 2023Stock$1,001 - $15,000N/A
Sheldon Whitehouse2 Aug 202227 Sept 2023Stock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$195.95M

Volume

126.02K

Beta

1.11

P/E Ratio

15.77

Fundamentals

EPS

$2.65

Div. Yield

0.67%

Open

$41.15

Day Range

$41.09 – $42.02

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
AMEX · USD
Country
US
IPO Date
2019-06-14

The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically ch...

No earnings data available for this stock.

Dividends

Dividend History

15 Jun 2026
Amount $0.1254
16 Dec 2025
Amount $0.1555
16 Jun 2025
Amount $0.1529
17 Dec 2024
Amount $0.1111
11 Jun 2024
Amount $0.1114
20 Dec 2023
Amount $0.1693
7 Jun 2023
Amount $0.0708
9 Jun 2022
Amount $0.1359
13 Dec 2021
Amount $0.2564
10 Jun 2021
Amount $0.0521
14 Dec 2020
Amount $0.0362
15 Jun 2020
Amount $0.0837
16 Dec 2019
Amount $0.2402

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

BRK-B

Berkshire Hathaway Inc.

47
$503.09-2.39 (-0.47%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

CIBR

First Trust NASDAQ Cybersecurity ETF

47
$101.67+0.72 (+0.71%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

IAU

iShares Gold Trust

47
$77.50-3.16 (-3.92%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

Frequently Asked Questions about IDNA

Which members of Congress have traded IDNA?
1 member of Congress has disclosed 7 trade in iShares Genomics Immunology and Healthcare ETF (IDNA) under the STOCK Act: Sheldon Whitehouse.
When was IDNA most recently disclosed by Congress?
The most recent IDNA disclosure was a sale by Sheldon Whitehouse on 3 March 2023.
What is the total disclosed congressional trading volume for IDNA?
Members of Congress have disclosed approximately $24K in IDNA sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in IDNA?
This IDNA page updates as soon as new STOCK Act disclosures are filed for iShares Genomics Immunology and Healthcare ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.